| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.28 | 0.06 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.31 | 0.06 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.07 |